Qin, Xiali
32  results:
Search for persons X
?
2

Gut microbiota and metabolites as predictors of biologics r..:

Wang, Chen ; Gu, Yu ; Chu, Qiao...
Microbiological Research.  282 (2024)  - p. 127660 , 2024
 
?
3

Selection strategy of second-line biologic therapies in adu..:

Zhang, Hu ; Mu, Chenlu ; Gu, Yu...
Pharmacological Research.  202 (2024)  - p. 107108 , 2024
 
?
4

Bile acid–gut microbiota crosstalk in irritable bowel syndr..:

Gu, Yu ; Li, Lingfeng ; Yang, Min...
Critical Reviews in Microbiology.  49 (2022)  3 - p. 350-369 , 2022
 
?
5

Saccharomyces boulardii, a yeast probiotic, inhibits gut mo..:

Gu, Yu ; Wang, Chen ; Qin, Xiali...
Pharmacological Research.  181 (2022)  - p. 106291 , 2022
 
?
 
?
8

Gut mycobiome: A promising target for colorectal cancer:

Qin, Xiali ; Gu, Yu ; Liu, Tianyu...
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.  1875 (2021)  1 - p. 188489 , 2021
 
?
10

Diagnostic Value of Gd‐EOB‐DTPA‐Enhanced MRI for the Expres..:

Chen, Yidi ; Qin, Xiali ; Long, Liling...
Journal of Magnetic Resonance Imaging.  51 (2019)  6 - p. 1755-1763 , 2019
 
?
11

Gut Microbiota-Derived Metabolites in Colorectal Cancer: Th..:

Zhang, Wanru ; An, Yaping ; Qin, Xiali...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558397/.  , 2021
 
?
 
?
13

Saccharomyces boulardii, a yeast probiotic, inhibits gut mo..:

Yu Gu ; Chen Wang ; Xiali Qin...
http://www.sciencedirect.com/science/article/pii/S1043661822002365.  , 2022
 
?
14

Gut Microbiota-Derived Metabolites in Colorectal Cancer: Th..:

Wanru Zhang ; Yaping An ; Xiali Qin...
https://www.frontiersin.org/articles/10.3389/fonc.2021.739648/full.  , 2021
 
?
15

The Potential Role of Gut Mycobiome in Irritable Bowel Synd..:

Yu Gu ; Guoqiong Zhou ; Xiali Qin...
https://www.frontiersin.org/article/10.3389/fmicb.2019.01894/full.  , 2019
 
1-15